ARCHIVES

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

This article is from The Cancer Letter archive.

Vol. 26 No. 37 | October 13, 2000

Download PDF Visit The Full Archive

Related Articles

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

Center Studies Prevention For Endometrial Cancer

February 25, 2005

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977

In Brief: AMA Issues Guidelines For HIV Infection, Smoking Cessation; MDA Appointment

February 4, 1994